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Summary: The performance of an enzymatic colorimetric method for the determination of inorganic phos-
phorus in serum and urine is described. Phosphate ions react with inosine in the presence of purine nucleoside
phosphorylase to form hypoxanthine; this is oxidized by xanthine oxidase to uric acid with production of
hydrogen peroxide. The latter is determined with the aid of the chromogen system peroxidase/4-aminophen-
azone/N-ethyl-N-iS^methylpheny^-N'-acetylethylenediamine, the coloured product being measured at 555 nm.
This series of reactions is completed in 5 min at 37 °C. The test is linear up to 240 mg/1. Analytical recovery
in serum averaged 101.2 ± 1.2% and in urine 101.9 + 3.2%. Within-run and between-run precision studies
in serum and urine samples gave CVs < 4.54% (at 22.0 mg/1). Results obtained by this method agree
(r = > 0.983) with the molybdate UV and molybdenum blue methods. Interference by endogenous substances,
including organic phosphate, was negligible.
η ο uc on these methods are used nevertheless in the clinical
Most techniques for the determination of inorganic laboratory, especially those based on direct proce-
phosphorus in serum or other biological fluids are dures without deproteinization. Many attempts have
based on phosphomolybdate complex formation by been made to develop enzymatic methods: phospho-
reaction of inorganic phosphate with molybdate in rylase, phosphoglucomutase and glucose-6-phosphate
acid solution. dehydrogenase have been used to generate NADPH
-ι- ι ι ,. ι n * * Λ fr°m inorganic phosphate and glycogen (2, 3). Gly-This colourless to pale yellow compound can be de- i J i . J n u u * ^ u j Λ. · . , . ' , t τΑτ , - t_ , - ceraldehyde-3-phosphate dehydrogenase was used astermmed directly by UV absorption, or by colon- t · i* *· *· * ι Λ* ' . , ~ a key enzyme in an alternative enzymatic route lead-
metric measurement after reduction to molybdenum . J ΧΤΑΤ^ΤΤ /A\ rr /c\ «. · -+u« , t . . t ' . . ;;. ing to NADH (4). Hwang (5) reacts inosine withblue or complexmg with dyes such as malachite green * u * - * u % · i -A uphosphate in the presence of punne nucleoside phos-
^" phorylase:1) the resulting hypoxanthine, in the pres-
These methods have several drawbacks: the direct UV ence of milk xanthine oxidase,1) produces uric acid,
method is affected by serum turbidity or pigmenta- which is determined from its absorbance at 293 nm.
tion; the molybdenum blue method is influenced in
its specificity, sensitivity and colour stability by the — -
type of reducing agent used; and the strongly acidic !) Enzymes:
.... "* *t; ι i ·* i_ j i^ Purme nucleoside phosphorylase (EC 2.4.2.1)conditions of the malachite green method may result Xanthine oxidase (EC 1.1.3.22)
in hydrolysis of organic phosphate. Peroxidase (EC 1.11.1.7)
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All these enzymatic methods, however, have various
limitations such as the need for reading in the UV
range; poor stability of substrates or enzymes; unfa-
vourable reaction equilibrium; and laborious proce-
dures. Significant developments have been reported
by Fossati (6) and Machida (7), both using the Hwang
enzymatic sequence. More precisely, Fossati assayed
the Superoxide ion (formed as hydrogen peroxide pre-
cursor during hypoxanthine oxidation) by reducing a
tetrazolium salt to formazane; Machida assayed phos-
phate, likewise in the visible region, using the perox-
idase/phenol/4-aminophenazone chromogen system
with an appropriate microbial xanthine oxidase.
A fully enzymatic colorimetric method based upon
the Machida enzymatic sequence has been recently
described (8, 9).
The reaction is illustrated in figure 1: inorganic phos-
phate reacts with inosine in the presence of purine
nucleoside phosphorylase (EC 2.4.2.1) to form hy-
poxanthine and ribose-1-phosphate. Hypoxanthine is
then oxidized by xanthine oxidase (EC 1.1.3.22) to
hydrogen peroxide and xanthine, which is in turn
oxidized to uric acid with further production of hy-
drogen peroxide. The hydrogen peroxide thus formed
reacts with the chromogen system 4-aminophenazone/
N-ethyl-N-(3-methylphenyl)-N'-acetylethylenedi-
amine, in the presence of peroxidase (EC 1.11.1.7), to
produce a purple-red dye.
In this paper we report in full the performance char-
acteristics of this method for both serum and urine.
Materials and Methods
Apparatus
A double-beam spectrophotometer with temperature-controlled
cuvette holder (Model Lambda 5, Perkin Elmer Corp., Nor-
walk, CT 06856) was used for all the spectrophotometric stud-
ies.
A CentrifiChem® System 400 (Baker Instruments Corp., Allen-
town, PA) was used for all the other studies.
Reagents
The reagent kit for the inorganic phosphate assay (SERA-
PAK® enzymatic colorimetric method, code 6683) was from
Miles Italiana S. p. A., Ames Division, Cavenag Brianza
(Italy).
The kit contains reagents to make two solutions in Pipes buffer
(20 mmol/1, pH 6.25). Solution 1 contains 1.8 mmol of N-ethyl-
N-(3-methylphenyl)-N'-acetylethylenediamine, ^ 50 U of xan-
thine oxidase, and > 2400 U of peroxidase per liter of Pipes.
Solution 2 contains 1.3 mmol of inosine, >50U of purine
nucleoside phosphorylase, > 70 U of xanthine oxidase,
> 1200 U of peroxidase, and 0.7 mmol of 4-aminophenazone
per liter of Pipes. Both solutions are stable for four weeks at
2-8 °C.
A "single working solution" can be prepared by mixing equal
volumes of Solution 1 and 2. Stored in a dark container pro-
tected from direct light, this solution will keep for three days
at 2-8 °C and for one day at 15-25 °C.
The kit also contains a calibration standard of potassium di-
hydrogen phosphate equivalent to 50 mg/l (1.61 mmol/1) of
inorganic phosphorus.
Procedures
Serum and diluted urine (1:10 with distilled water) were used
as samples.
L^^P ,n ι ,HP042-/H2P04--l·
OH
^ Π Ν Purine nucleoside
I I I I ^































Fig. 1. Reaction sequence: enzymatic colorimetric assay of inorganic phosphate.
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Manual two-step procedure
Add 20 μΐ of sample (or standard) to 1.5 ml of Solution 1, mix
and incubate at 37 °C for 2-5 minutes. Add 1.5 ml of Solution
2; mix and incubate 5 minutes at 37 °C, then read at 555 nm
against the reagent blank. The results reported for the manual
procedure were obtained by this method.
Manual one-step procedure
The assay can also be carried out as follows: add 20 μΐ of
sample (or standard) to 3.0 ml of "single working solution",
mix and incubate 5 minutes at 37 °C. Read at 555 nm vs the
reagent blank.
Automated procedure
The following instrument setting was used for CentrifiChem:
temperature 37 °C; wavelength 550 nm; sample volume 5 μΐ,
wash volume 55 μΐ; single working solution 350 μΐ; 1st reading
time 3 s; time interval 300 s; control standard 50 mg/1.
This procedure was validated by assaying 60 human sera by
the automated procedure (y) and by the manual one-step pro-
cedure (x). Calculated linear regression was: y = 0.990x + 0.3





Fig. 2. Colour development curves at 20 °C (—) and 37 °C (-)
for inorganic phosphorus standard at 50 mg/1 (a),
normal human serum (b), and abnormal human serum
(c).
Comparison methods
For the UV method without deproteinization (10) we used the
Inorganic Phosphorus Reagent kit from F. Hoffmann-La Roche
& Co. Assays were made by the fixed-time technique on a
CentrifiChem 400 system at 37 °C with reading at 340 nm.
For the molybdenum blue method with /?-methylaminophenol
sulphate as reducing agent (11) without deproteinization we
used the Phosphorus Autq/Stat® Diagnostic kit from Lancer
Division of Sherwood Medical (Ireland). Assays were made
manually.
Reference intervals
Serum samples were taken from 152 adult blood donors (75
men and 77 women). The reference limits were determined by
a non-parametric technique (12).
Twenty-four hour urine samples were collected from 48 healthy
adults (19 men and 29 women). Because of the small number
of samples, the reference limits were determined by parametric
technique, after checking the Gaussian distribution.
Control sera
We used the following commercially available control sera:
Monitrol (Merz & Dade); Precinorm, Precilip (Boehringer
Mannheim); Validate (General Diagnostics); Wellcomtrol (Well-
come); Ortho (Ortho); Roche (Roche); Kontrollogen (Behring-




The dye has an absorption peak at 555 nm. The
absorption spectrum is broad enough to allow meas-
urements in the range of 540—560 nm without sig-
nificantly affecting sensitivity.
Colour development
We tested human sera and urines both normal and
pathological for colour development rates. Complete
colour development occurred within 5 min at 37 °C
or less than 10 min at room temperature (18 — 25 °C).
Examples of colour development for aqueous inor-
ganic phosphorus standard and human sera are shown
in figure 2.
After the recommended incubation time, no signifi-
cant colour changes were seen at room temperature
for at least 2 hours.
Linearity range and sensitivity
We assessed (sample/reagent ratio of 1/150) method
linearity and sensitivity with aqueous phosphate so-
lutions. When net absorbance was plotted versus in-
organic phosphorus concentration, the response
proved linear up to 240 mg/1 (regression equation
y = 0.0758 χ + 0.007; r = 0.9999).
Absorbance per mg of phosphorus (1 cm light path)
is 0.076, representing dye molar lineic absorbance of
1780 m2 -mol"1 at 555 nm. For the CentrifiChem
instrument, this requires a sample/reagent ratio of
1/80; the linear range extends to 120 mg/1.
Recovery
Recovery tests, made by spiking serum and urine
pools with NBS potassium dihydrogen phosphate,
gave (tab. 1) an average recovery of 101.2 ± 1.2%
(SD) for serum and 101.9 ± 3.2% (SD) for urine.
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Tab. 1. Analytical recovery Tab. 2. Precision data



























































































a over a 15-day period
Precision
We assessed assay precision by replicate analysis of
various human serum and urine pools at different
phosphate concentrations. Table 2 shows the results
obtained.
Method comparison
We explored the correlation between the enzymatic
colorimetric method and two chemical methods, the
phosphomolybdate UV method and the molybdenum
blue method, in routine serum and urine assays. Re-
sults were processed by least-square regression anal-
ysis (13); correlation plots and statistical parameters
are shown in figures 3 and 4.
Interferences
We explored the effects of known potential interfer-
ents in Trinder-type reactions, either endogenous or
exogenous (bilirubin, haemoglobin, ascorbic acid,
drugs such as L-dopa and its metabolite 3,4-dihy-
droxyphenylacetate, and α-rnethyldopa), by spiking
pooled human sera at normal inorganic phosphorus
concentration with known amounts of these sub-
stances (for haemoglobin we used washed and lysed
erythrocytes). We also tested the effect of hypoxan-
thine and xanthine, since these occur in the reaction*.
Allopurinol was tested as a known inhibitor of xan-
thine oxidase. The effect on test results of some rep-
resentative organic phosphates, as well as of the more
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Fig. 3. Correlation plots for serum samples. Regression parameters are for
a) enzymatic colorimetric method (y) vs phosphomolybdate UV method (xV
y = 0.949x + 2.6; r = 0.985; Syx = 2.8; χ = 44.2; y = 44.5; n = 98;
b) enzymatic colorimetric method (y) vs molybdenum blue method (xY
y = 0.969x + 3.8; r = 0.983; S^ = 3.1; χ = 43.0; y = 45.5; n = 75.
J. Clin. Chem. Clin. Biochem. / Vol. 26,1988 / No. 6
Berti et al,: Determination of inorganic phosphorus in serum and urine 403
1600
200 400 600 800 1000 1200 1400 1600
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Fig. 4. Correlation plots for urine samples. Regression parameters are for
a) enzymatic colorimetric method (y) vs phosphomolybdate UV method (x):
y = 1.06x + 17.3; r = 0.995; Syx = 35.9; x = 660.8; y = 719.2; n = 123;
b) enzymatic colorimetric method (y) vs molybdenum blue method (x):
y = 0.958x + 53.9; r = 0.989; S^ = 58.6; x = 709.4; y = 733.6; n = 121.
larly. Results were assessed by analysing aliquots of
pools with and without the interferent in ten repli-
cates; means ± 3 SD were calculated and values out-
side this range were taken to indicate interference. No
interference was found for concentrations as great as
those shown in table 3.
Reference intervals
The reference limits, 2.5th-97.5th percentiles (0.90
confidence intervals) for serum inorganic phosphorus
were: 24 (22—26)-45 (43—46) mg/l. For urine spec-












































imens the reference limits (χ ± 2 SD) were 134-1320
mg/24 h, with a mean value of 727 mg/24 h.
Values for the two sexes did not show a statistically
significant difference (t-test, p > 0.05).
Control sera
We ran tests on several control sera from different
sources. The values obtained and the claimed control
sera values are shown in table 4. It should be pointed
out that large differences exist among the claimed
values by the different chemical methods; therefore
the two extreme assay values (and the overall accept-
able ranges) are given in the table.
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Discussion
Existing chemical methods for assaying inorganic
phosphorus in biological fluids generally lack suffi-
cient specificity and ease of execution — two main
considerations for routine use. The method at issue
is highly specific and easy to perform, being based on
an appropriate enzymatic reaction coupled with a
sensitive colorimetric measurement.
Method linearity (up to at least 240 mg/1) is broad
enough to make reassays unnecessary. Owing to the
high sensitivity, precision is very good at the various
phosphate levels tested, including the low ones. Com-
parative studies versus the phosphomolybdate UV
method and the molybdenum blue method showed
good agreement for both serum and urine.
High bilirubin and ascorbic acid concentrations, as
well as moderate haemolysis do not affect results;
haemoglobin above 1 g/1 causes increased absorption
and leads to phosphorus overassay.
Endogenous hypoxanthine and xanthine might inter-
fere by generating stoichiometric amounts of hydro-
gen peroxide; but they are neutralized in the two-step
procedure by reaction with N-ethyl-N-(3-methyl-
phenyl)-N'-acetylethylenediamine during preincuba-
tion, forming a colourless product in the absence of
inosine and 4-aminophenazone.
No interference from these oxypurines was seen with
concentrations in excess of values ever found in serum
(14). It should, however, be noted that even in the
one-step procedure the results are affected only at
very high values, such as those of patients receiving
allopurinol (15). Allopurinol showed no inhibitory
effect of its own. For L-dopa and α-methyldopa, a
borderline negative interference may occur; no inter-
ference from 3,4-dihydroxyphenylacetate was noted.
Organic phosphates with relatively high free energy
of hydrolysis (> 21 kJ/mol ^ ^ 5.0 kcal/mol) are
easily degraded in an acidic medium and are reported
to interfere more or less significantly in chemical assay
methods for inorganic phosphate (1). We tested a
variety of phosphate links (ester, acetal, phosphoric
acid anhydride, and amidophosph te) and found that
none would interfere in the present method, even at
concentrations much higher than those found in
serum (16) or likely to be released by moderate hae-
molysis. Anticoagulants did not interfere.
In conclusion the method discussed in this paper
shows good sensitivity, linearity and precision. With
respect to accuracy, the method offers the advantage
over chemical procedures of being free of interference
from organic phosphate. Added advantages are the
use of noncorrosive reagents, ease of handling, arid
adaptability to clinical laboratory instruments.
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